Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC 4-acetamido-N-(tert-butyl)benzamide | 183619-38-7 | MFCD00774476 | 99.8% | 234.29 g/mol | C13H18N2O2 | 25 MG
Supplier: Medchemexpress LLC HY10037625MG
CPI-1189 is a small-molecule, orally active inhibitor of tumor necrosis factor-alpha (TNF-α) release that inhibits p38 MAPK phosphorylation and can prevent apoptosis. It is used as a research tool in studies of neuroprotection, inflammation, HIV-related pathology, and neurodegenerative disease models.
- Orally active TNF-α release inhibitor.
- Inhibits p38 phosphorylation to modulate inflammatory signaling.
- Demonstrated neuroprotective and antiapoptotic effects in cellular models.
- High chemical purity suitable for biological research.
- Solid, white to off-white appearance for easy handling.
- Supplied in research-scale quantities for laboratory use.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?